4//SEC Filing
Ramachandra Sumant 4
Accession 0001415889-25-008942
CIK 0001806952other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 6:46 PM ET
Size
5.3 KB
Accession
0001415889-25-008942
Insider Transaction Report
Form 4
Ramachandra Sumant
Director
Transactions
- Purchase
Common Stock
2025-03-21$0.58/sh+200,000$115,220→ 200,000 total(indirect: By Trust)
Footnotes (2)
- [F1]The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.5487 to $0.5879, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range.
- [F2]Shares held by the Sumant Ramachandra Rev Trust DTD 01/24/12. The Reporting Person is grantor and trustee of the Sumant Ramachandra Rev Trust DTD 01/24/12.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001439368
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 6:46 PM ET
- Size
- 5.3 KB